# Exo

> Exo is a Santa Clara medical imaging company building a point-of-care ultrasound ecosystem around Iris, a 300-gram handheld scanner; SweepAI, its on-device guidance and measurement software; and Exo Works, a cloud workflow layer for documentation, review, quality assurance, education, integration, and billing. It sells the probe directly and packages broader capabilities for individual clinicians, departments, and health systems.

- **Founded:** 2015
- **Headquarters:** Santa Clara, United States
- **Founders:** Sandeep Akkaraju (Co-founder and CEO), Janusz Bryzek (Co-founder and late Executive Board Chairman), Yusuf Haque (Co-founder, CTO and EVP of Engineering), John Kokulis (Co-founder and Advisory Board Member)
- **Team size:** Approximately 185-190 employees; LinkedIn lists 51-200 employees.
- **Products:** Exo Iris, Exo Works, SweepAI, Exo U, Exo Works Connect
- **Notable:** Received FDA 510(k) clearance for Exo Iris in 2021, with subsequent clearances for device and AI capabilities., Launched Exo Iris commercially in September 2023., Built a 300-gram, IP67-rated, one-meter drop-tested probe with three imaging geometries and depths up to 30 cm.

## Products & services

- **Exo Iris** — A 300-gram FDA-cleared handheld ultrasound device with linear, curved and phased-array imaging, 22 exam types, Doppler modes and a silicon pMUT array.
- **Exo Works** — POCUS workflow software for exam documentation, review, storage, sharing, quality assurance, proficiency tracking, EHR integration and billing workflows.
- **SweepAI** — On-device, real-time AI that guides image acquisition and provides automated cardiac, lung, IVC and bladder indicators; commercialized functions are FDA-cleared for their stated uses.
- **Exo U** — In-app ultrasound education with short scan tutorials, anatomical guidance and feedback designed for novice POCUS learners.
- **Exo Works Connect** — A self- or white-glove-installed tier for multi-user collaboration, QA, proficiency tracking, fleet management and connection to DICOM-enabled ultrasound devices.

## Achievements

- Received FDA 510(k) clearance for Exo Iris in 2021, with subsequent clearances for device and AI capabilities.
- Launched Exo Iris commercially in September 2023.
- Built a 300-gram, IP67-rated, one-meter drop-tested probe with three imaging geometries and depths up to 30 cm.
- Introduced FDA-cleared SweepAI cardiac and lung guidance in 2024.
- Won the 2024 MedTech Breakthrough award for Best New Ultrasound Technology Solution.
- Reached 10 FDA-cleared AI applications with Global Longitudinal Strain analysis in April 2025, according to Exo.
- Reached 14 FDA-cleared AI indicators after lung finding clearances in June 2025, according to Exo.
- Announced a strategic collaboration and equity investment from Samsung Medison in May 2025.

## Latest updates

- **2024-09** — Introduced SweepAI with FDA-cleared cardiac and lung scanning guidance on Exo Iris.
- **2024-09** — Published a Geisinger case study covering deployment across six institutes and 10 hospital campuses.
- **2024-10** — Introduced Exo U, an in-app approach to POCUS education built around short tutorials and SweepAI feedback.
- **2024-12** — Added AI indicators for hemodynamics and hypertension to Exo Iris.
- **2025-04** — Added FDA-cleared real-time Global Longitudinal Strain analysis, which Exo described as its tenth cleared AI application.
- **2025-05** — Announced a strategic collaboration and equity investment from Samsung Medison; Omar Ishrak joined the board as Chair of Strategy.
- **2025-06** — Launched FDA-cleared AI for detecting pleural effusion and consolidation/atelectasis at the point of care.
- **2026-06** — Company LinkedIn posts showed Exo Iris expanding into Chile and Costa Rica through local distribution partners.

## Links

- Website: https://exo.inc
- LinkedIn: https://www.linkedin.com/company/exoeffect/
- Twitter/X: https://twitter.com/exoeffect
- Instagram: https://www.instagram.com/exoeffect/
- Facebook: https://www.facebook.com/exoeffect/

---

Profile page: https://yespress.io/exo
Published by YesPress — https://yespress.io
Last updated: 2026-08-18